[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $ints

Intensity Therapeutics Inc. announces two presentations at the 2025 San Antonio Breast Cancer Symposium, focusing on INT2306 for breast cancer. The company also expanded its at-the-market offering program to $XX million for financial flexibility.

### About $ints
Intensity Therapeutics Inc. is a biotechnology company focused on developing cancer treatments.  

### Insights
- $ints engagements is up XXXXX% from the previous week.
- $ints posts created is up XXXXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ints/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ints/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXXXXX +62%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +1,420%  
X Year: XXXXXXXXX +577%  
1-Year High: XXXXXXX on 2025-10-30  
1-Year Low: X on 2025-02-03  

Engagements by network (24h):
Reddit: XX
TikTok: X
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ints/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ints/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXX +1,246%  
X Year: XXXXX +1,019%  
1-Year High: XXXXX on 2025-10-31  
1-Year Low: X on 2025-01-27  

Mentions by network (24h):
Reddit: XX
TikTok: X
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ints/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ints/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $ints in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +3,255%  
X Year: XXXXX +1,545%  
1-Year High: XXXXX on 2025-10-31  
1-Year Low: X on 2025-01-26  

The most influential creators that mention $ints in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@Berlinergy](/creator/twitter/Berlinergy)         | X    | XXXXX     | X     | XXX         |
| [@amazing_stocks](/creator/twitter/amazing_stocks) | X    | XXX       | X     | XX          |

[View More](/list/creators/$ints/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ints/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ints/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-09  
1-Year Low: XX% on 2024-12-24  

Most Supportive Themes:
- Phase X Trial Progress: (40%) Positive updates and anticipation surrounding the Phase X trial for INT2306, a breast cancer drug.
- Investment and Buy Zones: (20%) Posts indicating accumulation of shares at specific price points, suggesting confidence in future price increases.
  
Most Critical Themes:
- Clinical Trial Halts and Lack of News: (50%) Concerns about halted clinical trials and a general lack of recent positive news, leading to frustration.
- Negative Sentiment Around RS: (30%) Some posts express negative sentiment or caution regarding the reverse stock split, viewing it as a bad sign.
  

### Top $ints Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$INTS +10% -XXX day extension granted to regain nasdaq compliance w/ min bid requirement -Announced X Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium: 👉🏻Will present early observations from INVINCIBLE-4-SAKK 66/22 Ph X study on intratumoral Injections of INT230-6 Prior to Neoadjuvant Immuno-chemotherapy in Early-Stage Triple Negative Breast Cancer"  
[X Link](https://x.com/Berlinergy/status/1997050457685143827) [@Berlinergy](/creator/x/Berlinergy) 2025-12-05T21:08Z 7492 followers, XXX engagements


"$INTS Intensity announced they will present P2 Triple Negative Breast Cancer results on 2025-12-12 for INT230-6 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1997043218697855385) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-05T20:39Z 2982 followers, XXX engagements


"some green premarket movers $QCLS $RBRK $LGHL $VSCO $COO $TTTAN $CHPT $ULTA $INTS $BIDU $CAPR $U $LEU $MP $HUM $NVO $CRWV"  
[X Link](https://x.com/SunriseTrader/status/1996931197931606466) [@SunriseTrader](/creator/x/SunriseTrader) 2025-12-05T13:14Z 197.1K followers, 3257 engagements


"Intensity's clinical trials demonstrated the ability of INT230-6 to kill tumors & elicit an adaptive immune response within days of injection representing a new approach to cancer that holds the potential to shift the treatment paradigm $INTS #SABCS25"  
[X Link](https://x.com/MBCadvocate/status/1996768703019364396) [@MBCadvocate](/creator/x/MBCadvocate) 2025-12-05T02:28Z 1504 followers, XXX engagements